"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Syndax Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Syndax Pharmaceuticals Inc
Will Syndax Pharmaceuticals Continue to Surge Higher?
- Mar 5th, 2020 11:54 am
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss
- Mar 3rd, 2020 10:55 pm
Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update
- Mar 3rd, 2020 9:05 pm
Syndax Announces Participation at Two Upcoming Investor Conferences
- Feb 18th, 2020 12:00 pm
The CEO & Director of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX), Briggs Morrison, Just Bought 40% More Shares
- Feb 7th, 2020 4:05 pm
Syndax Pharmaceuticals, Inc. (SNDX) Shares March Higher, Can It Continue?
- Feb 4th, 2020 12:01 pm
Syndax Announces $35.0 Million Offering of Common Stock and Enters Term Sheet for Loan with Hercules Capital for up to $30 Million
- Jan 31st, 2020 12:00 pm
Science Magazine Publishes Results from Preclinical Study on the Activity of Menin-MLL Inhibition for the Treatment of NPM1 Acute Myeloid Leukemia
- Jan 30th, 2020 7:11 pm
Should Syndax Pharmaceuticals (NASDAQ:SNDX) Be Disappointed With Their 40% Profit?
- Jan 24th, 2020 3:20 pm
Syndax Pharmaceuticals Highlights 2020 Clinical and Corporate Outlook
- Jan 10th, 2020 9:05 pm
Should You Avoid Syndax Pharmaceuticals, Inc. (SNDX)?
- Dec 17th, 2019 9:39 pm
Are Insiders Buying Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock?
- Dec 10th, 2019 1:08 pm
Syndax Pharmaceuticals Announces Plans to Commence Phase 2 Expansion Cohort of SNDX-6352 for the Treatment of Chronic Graft Versus Host Disease
- Dec 10th, 2019 12:00 pm
Syndax Announces Preclinical Results Supporting Development of its Portfolio of Menin Inhibitors In Mixed Lineage Leukemias
- Dec 9th, 2019 9:05 pm
Edited Transcript of SNDX earnings conference call or presentation 7-Nov-19 9:30pm GMT
- Nov 17th, 2019 12:14 pm
Do Hedge Funds Love Syndax Pharmaceuticals, Inc. (SNDX)?
- Nov 11th, 2019 2:30 pm
Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Misses Revenue Estimates
- Nov 7th, 2019 10:55 pm
Syndax Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Business Update
- Nov 7th, 2019 9:05 pm
Syndax to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 7, 2019
- Oct 31st, 2019 11:00 am
Will Syndax Pharmaceuticals (SNDX) Report Negative Q3 Earnings? What You Should Know
- Oct 28th, 2019 2:32 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2020 VentureLine
Website developed by Digital Solutions